secwatch.observer — SEC 8-K summary
======================================

Issuer:     Whitehawk Therapeutics, Inc. (WHWK)
CIK:        0001422142
Form:       8-K
Filed at:   2022-03-17T23:59:59+00:00
Accession:  0001193125-22-078484
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aadi Bioscience enters $75M ATM equity offering agreement with Cowen
--------------------------------------------------------------------

- ATM facility allows Aadi to sell up to $75M in common stock at its discretion.
- Cowen will receive 3.0% commission on gross proceeds from any shares sold.
- Sales will be made on Nasdaq under existing shelf registration statement (S-3).
- Aadi has no obligation to sell any shares; program effective March 17, 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1422142/000119312522078484/0001193125-22-078484-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1422142/000119312522078484/d266766d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-078484

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer